HCG Support for Frozen Embryo Transfer in Obese Women
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether a hormone called HCG (human chorionic gonadotropin) improves pregnancy success when transferring a frozen embryo back into the uterus during a natural cycle. The study focuses on women with higher body weight, as they may respond differently to fertility treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 37 years old or younger
- You have at least one frozen embryo from a previous IVF cycle that is of good quality (rated 4BC or better on the Gardner scale) and is 5–6 days old
- Your BMI is 24 or higher (considered overweight by Asian population standards)
- You have not had more than one failed embryo transfer in the past
- Your uterus is structurally normal with no adenomyosis, blocked tubes, scar tissue, or fibroids
- If you have diabetes or an immune condition, it must be well-controlled with medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving hCG before transferring a thawed embryo can improve success. It is for women who have at least one frozen embryo of good quality and are planning a frozen embryo transfer.
This trial compares two protocols for preparing the uterus before transferring a frozen embryo. It aims to find which method works better for women with regular cycles and no ovulation issues.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
This trial tests a medication called human menopausal gonadotropin to help women undergoing IVF achieve a live birth. It focuses on the cumulative success rate after freezing and later transferring embryos.
This trial checks if taking extra hormones after a frozen embryo transfer (called luteal support) is needed when using your natural cycle. It may help improve pregnancy chances.
Hear when a new Obesity, Maternal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.